Home > Healthcare & Medical Devices > Endoscopy Market

Endoscopy Market Size By Product (Endoscopes {Rigid Endoscopes, Flexible Endoscopes, Capsule Endoscopes, Robot-Assisted Endoscopes}, Visualization Systems, Endoscopic Ultrasound, Insufflator), By Application (Arthroscopy, Laparoscopy, GI Endoscopy, Obstetrics/Gynecology, ENT Endoscopy, Pulmonary Endoscopy), By End-use (Hospitals, Ambulatory Surgical Centers), Industry Analysis Report, Regional Outlook, Application Potential, Competitive Market Share & Forecast, 2022 – 2030

  • Report ID: GMI2655
  • Published Date: Jul 2022
  • Report Format: PDF

Industry Overview

Endoscopy Market size was valued at around USD 33,480 million in 2021 and is estimated to witness a CAGR of 7% from 2022 to 2030 due to rise in geriatric population, availability of innovative endoscopy devices for endoscopy in developed regions such as Europe and North America, rising incidences of gastrointestinal disorders, cancer and other chronic conditions in Asia Pacific and increasing demand for minimally invasive procedures.
 

Endoscopy Market

Get more details on this report - Request Free Sample PDF
 

The older patients are more susceptible to chronic and acute ailments. Thus, the adoption of endoscopy procedures is more among the geriatric population base. As per the reports from the Administration of Community Living (ACL), the number of people of age 65 and older were 54.1 million in 2019 and is projected to grow around 94.7 million by 2060 in the U.S. Additionally, the rise in the prevalence in chronic diseases is anticipated to drive the endoscopy market growth further in the analysis timeframe.
 

A medical procedure using any type of endoscope is called an endoscopy. An endoscope is an optical instrument comprising of a flexible thin tube with a camera and light attached at the end. These devices are inserted directly into the organ or orifices for minimally invasive surgical procedures. The medical device is used to diagnose or in treatments while a practitioner looks inside a body cavity or organ for abnormalities.
 

However, dearth of skilled physicians and endoscopists in developing countries is among the major factors hampering the endoscopy market share. Health care resources in emerging and undeveloped nations are insufficient to guarantee that everyone has equal access to necessary health treatments. As a result, there are not enough trained clinical personnel resulting in inadequate healthcare facilities. Additionally, endoscopy instruments are relatively expensive.
 

A 2019, NCBI report gives an estimated cost range of the endoscopes. Conventional endoscopes have substantial purchase prices, ranging from $20,000 - $40,000 for an upper endoscopy and for a two-tube operating system, it costs over $80,000 to $120,000, to explore both the upper and lower gastrointestinal tract. An additional endoscopic ultrasound system usually costs over $200,000. The affordability of endoscopic systems is somewhat difficult due to the price point, which makes professional training more difficult.
 

The COVID-19 pandemic has rendered a negative impact on the endoscopy industry during the spread of the outbreak. Globally, the coronavirus outbreak affected a significant population, which led to an increase in infection fatality rates. To stop the virus from spreading, numerous countries throughout the world enacted nationwide lockdowns and emergencies.
 

Due to the pandemic's increased patient influx and changes in diagnostic procedures, the healthcare systems were severely affected. Endoscopic procedures that were scheduled during the pandemic were postponed or delayed because they were viewed as nonemergent. Because these procedures necessitate direct patient contact, the risk of infection to medical personnel and other patients may be increased.
 

In a report cited in the BMJ journal, the data suggests, there has been 58% overall reduction in rate of Endoscopic cancer detection and in case of colorectal cancer, the reduction is close to 72%, during the study period. Additionally, healthcare facilities began providing surgical care as the number of COVID-19-infected patients declined in various nations. They also increased the number of endoscopic operations, gradually bringing the volume of procedures back to pre-pandemic levels by 2021.
 

The COVID-19 pandemic thus had a detrimental effect on the endoscope market in 2020, which gained momentum in the later stages during 2021. In the upcoming years, it is anticipated that declining COVID-19 infection rates and patient numbers as well as rising procedure volume will support market expansion.
 

Increasing demand for minimally invasive procedures is anticipated to amplify the market statistics

The rising prevalence of chronic diseases such as gastrointestinal disorders and cancer of mucosal lining has added to the increasing disease burden requiring endoscopic interventions. The rise in these diseases has assertively affected the adoption of endoscopy in therapeutic and diagnostic purposes.
 

As per the recent reports from the American Cancer Society, there are over 26,380 new cases of stomach cancer observed in 2022, accounting for 1.5% of all cancers diagnosed. To diagnose the extent of the disease, practitioners undertake laparoscopic procedures. Laparoscopy is a minimally invasive procedure that allows a surgeon to view inside of the abdomen and pelvis avoiding making major skin incisions.
 

The growing preference for minimally invasive procedures is fuelled by technological advancements, high-quality of therapy, shorter hospital stays, and easier recovery. Clinical practitioners use minimally invasive treatments to perform procedures that cause less damage to the patient. Moreover, the rise in number of ambulatory surgical centers also add to the increasing demand for the minimally invasive procedures, further propelling the endoscopy market growth.
 

The rising prevalence of gastrointestinal disorder is set to promote the market demand

Global Endoscopy Market Size, By Product

Get more details on this report - Request Free Sample PDF
 

Based on product, the market is segmented as endoscopes, visualization systems, endoscopic ultrasound, insufflator, and others. The endoscopes segment accounted for the major market share, garnering the revenue of over USD 16,811 million in 2021 and is anticipated to witness robust growth during the projected timeline. The growth in the segment is attributed by the rise in incidents of chronic diseases such as gastrointestinal disorders and cancer. As per the epidemiology study published by the NCBI in 2018, around 11% of the total population in the U.S. suffer from chronic digestive diseases.
 

Technological advancements in endoscopy procedures are expected to surge the business landscape

Based on application, the endoscopy market is segmented as arthroscopy, laparoscopy, GI endoscopy, obstetrics/gynaecology, ENT endoscopy, pulmonary endoscopy, and others. The laparoscopy segment held a dominant market share in 2021 and is expected to reach more than USD 16,716 million by 2030 owing to the rise in laparoscopic procedures and technological advancements in endoscopy. The technologically advanced endoscopes play an important role and can be used for early detection of diseases and help in early diagnosis and treatment. Advanced laparoscope devices assist in cancer or other abnormality detection, and several other breakthroughs thereby surging the procedure’s result and success rate. Moreover, increasing prevalence of diseases such as cancers, requiring laparoscopic interventions, contribute to the rising adoption of the procedure.
 

As per the epidemiology study cited in the NCBI, the gastric cancer is deemed as 5th most common forms of cancers with high mortality and caused over 783,000 deaths in 2018. Thus, with rising disease prevalence and technological advancement in endoscopic procedures, the market is anticipated to grow exponentially in the foreseeable future.
 

Rise in geriatric population will drive the hospital admissions and is expected to drive the market expansion

Global Endoscopy Market Share, By End-Use

Get more details on this report - Request Free Sample PDF
 

By end-use, the hospitals segment held a dominant market share in 2021 and is estimated to witness steady growth to reach over USD 32,677 million by 2030 owing to hospitals using more sophisticated endoscopic techniques, that are expected to boost patient preference for hospitals. The market will rise further because of an increase in hospital admissions for gastrointestinal diseases, cancer, and other chronic ailments. Other factors that are favourably influencing the expansion of the hospitals segment include the rise in disease screening tests and the accessibility of highly skilled healthcare workers. Furthermore, it is projected that the segment growth will be favourably impacted by the robust healthcare infrastructure and suitable patient assistance. Additionally, the incidence of cancer, infections, and metabolic diseases among the ageing population will increase the rate of hospital diagnosis and treatment. As per the 2018 NCBI report, the prevalence of the gastrointestinal disorders was recorded to be as high as 35% in older patients of age 65 and above.
 

Innovative endoscopic devices in North America will spur the industry revenue

Global Endoscopy Market Size, By Region

Get more details on this report - Request Free Sample PDF
 

The U.S. dominated the North America endoscopy market with a majority market share in 2021 and is anticipated to progress at a notable pace to reach over USD 23,831 million by 2030 due to numerous factors such as growing geriatric population worldwide, innovative endoscopy devices for endoscopy in developed regions such North America, rising incidences of gastrointestinal disorders, cancer, and other chronic conditions, and increasing demand for minimally invasive procedures. Endoscopy techniques are instrumental in detecting numerous ailments. Lung cancer for example, can be detected using pulmonary endoscopic procedures, and with the rise in prevalence in the lung diseases, the adoption of these endoscopic procedures also rises.
 

For instance, as per the American Lung Association data, the number of new cases of lung cancer were over 236,740 in 2022 with high mortality rate, accounting for over 130,180 deaths. Moreover, the technological advancements have led to innovative endoscopy devices that are reliable and accurate in diagnosis and therapeutics.
 

Major players are constantly engaged in R&D activities, developing innovative technologies and new product development to improve the efficacy and accuracy of the endoscopy treatment. For instance, Stryker Corporation launched their 1688 AIM 4K Visualization platform, and the Connected OR Hub, that help in enhancing surgical experience for arthroscopy. Hence, the commercialization of such advanced endoscopes will accelerate business growth over the coming years.
 

Strategies adopted by major market players will surge the industry outlook

Some of the major market players operating in the endoscopy industry are B Braun Melsungen AG, Olympus Corporation, Intuitive Surgical, Inc., Boston Scientific Corporation, Ethicon US, LLC (J&J), and Fujifilm Corporation, among others. These market players concentrate on strategic developments such as partnerships, new product launch & commercialization, vertical integration for business expansion. Furthermore, these players are heavily investing in R&D activities that enables them to innovate & capitalize on these products that further helps to garner maximum revenue in the market.
 

Recent industry developments:

  • In December 2019, Boston Scientific Corporation announced, EXALT Model D Single Use Duodenoscope received FDA clearance. The device is used in endoscopic retrograde cholangiopancreatography procedures. The device is the first and only (disposable) duodenoscope that has been granted FDA clearance. Clearances such as this enabled the firm to set a strong customer base and propel the business forward.
     
  • In October 2017, Fujifilm announced the launch of ELUXEO and sets. This next-generation endoscopic video imaging system go in line with the firm’s endoscopy portfolio, providing physicians with the tools they need to enhance results. Thus, additions such as these helped the company diversify and enhance its endoscopy portfolio, thereby solidifying its industry position.
     

Endoscopy market research report includes an in-depth coverage of the industry with estimates & forecast in terms of revenue in USD from 2022 to 2030, for the following segments: 

By Product

  • Endoscopes
    • Rigid Endoscopes
    • Flexible Endoscopes
    • Capsule Endoscopes
    • Robot-Assisted Endoscopes
  • Visualization Systems
  • Endoscopic Ultrasound
  • Insufflator
  • Others

By Application

  • Arthroscopy
  • Laparoscopy
  • GI endoscopy
  • Obstetrics/Gynecology
  • ENT endoscopy
  • Pulmonary endoscopy
  • Others

By End-use

  • Hospitals
  • Ambulatory Surgical Centers
  • Others

The above information is provided for the following regions and countries:

By Region

  • North America
    • U.S.
    • Canada
  • Europe
    • Germany
    • UK
    • France
    • Spain
    • Italy
  • Asia Pacific
    • China
    • Japan
    • India
    • Australia  
    • South Korea 
  • Latin America
    • Brazil
    • Mexico
    • Argentina
  • Middle East & Africa
    • South Africa
    • Saudi Arabia
    • UAE

 

Authors: Sumant Ugalmugle, Rupali Swain

Frequently Asked Questions (FAQ) :

Global market for endoscopy was valued at over US$33.48 billion in 2021 and is estimated to register a 7% CAGR during the forecast period of 2022-2030.

Global endoscopy industry revenue from the endoscope product segment surpassed US$16.81 billion in 2021 due to the rising incidence of chronic diseases, such as cancer and gastrointestinal disorders.

Global endoscopy market value from the laparoscopy application segment is expected to cross US$16.71 billion by 2030 with the awareness about early detection and treatment of diseases and access to advanced equipment.

U.S. endoscopy market share is anticipated to surpass US$23.8 billion by 2030, with increase in geriatric population, medical device innovations, modern healthcare infrastructure and rising cases of chronic conditions.

Buy Now

Access to only 1 person; cannot be shared; cannot be printed
Access for 2 to 5 users only within same department of one company
Access to a company wide audience; includes subsidiary companies or other companies within a group of companies
Immediate Delivery Available

Premium Report Details

  • Base Year: 2021
  • Companies covered: 15
  • Tables & Figures: 259
  • Countries covered: 18
  • Pages: 196

Get a report that explains COVID-19 impact on this market

 Request Free Sample

Budget constraints? Get in touch with us for special pricing

Request Discount